Crystal structure of TcACHE complexed to 1-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-a]isoindol-10-yl)-3-(4-(1-(2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)-1H-1,2,3-triazol-4-yl)pyridin-2-yl)urea
Coordinates
PDB Format
Method
X-RAY DIFFRACTION
1.86 Å
Oligo State
homo-dimer
Ligands
1 x
NAG-
NAG:
2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.1:
3
residues within 4Å:
Chain A:
N.59,
S.61,
T.62
No protein-ligand interaction detected (PLIP)
5 x
NAG:
2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
2 x
FW8:
1-[(10~{b}~{S})-6-oxidanylidene-2,3,4,10~{b}-tetrahydro-1~{H}-pyrido[2,1-a]isoindol-10-yl]-3-[4-[1-[2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl]-1,2,3-triazol-4-yl]pyridin-2-yl]urea(Non-covalent)
Oukoloff, K. et al., Design, biological evaluation and X-ray crystallography of nanomolar multifunctional ligands targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3. Eur.J.Med.Chem. (2019)